Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 139
interventional 89
Observational 46
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 24
Drug 19
Other 13
Biological|placebo 10
Behavioral 6
Device 3
Biological 2
Biological|Procedure 2
Behavioral|Other|Radiation 1
Biological|Device 1
Biological|Drug 1
Biological|Drug|placebo 1
Biological|Other 1
Device|Diagnostic Test|Procedure 1
Device|Drug 1
Other|Procedure 1
Procedure 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
France 16
NA 7
China 5
Denmark 5
Norway 4
Belgium 3
United Kingdom 3
India 2
Netherlands 2
Poland 2
Argentina|Belgium|Colombia|Czech Republic|Finland|France|Germany|Hungary|Korea, Republic of|Netherlands|Russian Federation|Spain|Taiwan|United Kingdom 1
Bangladesh 1
Belgium|Bosnia and Herzegovina|Bulgaria|Czechia|Estonia|Georgia|Latvia|Poland|Spain|Ukraine 1
Belgium|Bulgaria|Croatia|Czechia|Estonia|Finland|Greece|Ireland|Italy|Latvia|Lithuania|Poland|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Brazil 1
Bulgaria|Czechia|Germany|Greece|Italy|Slovakia|Spain|United Kingdom 1
Canada 1
China|Czechia|Korea, Republic of|United Kingdom 1
Czechia|Germany|Netherlands|Poland|Romania|Russian Federation|Spain|Turkey|Ukraine 1
Czechia|Germany|Netherlands|Poland|Spain 1
Egypt 1
France|Germany 1
France|Monaco 1
Germany 1
Germany|Hungary|United States|Argentina|Belgium|Brazil|Canada|Czechia|France|Italy|Mexico|Netherlands|Poland|Spain|United Kingdom 1
Hong Kong 1
Italy 1
Japan|Korea, Republic of|Taiwan 1
Korea, Republic of 1
Lebanon 1
Mexico 1
Mexico|United States|Argentina|Hungary|Poland|Russian Federation|Spain|Ukraine 1
Norway|Sweden 1
Singapore 1
Switzerland|United States|France|Netherlands 1
United States 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|New Zealand|Poland|Russian Federation|Slovakia|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Austria|Brazil|Canada|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Austria|Brazil|Canada|Czechia|Finland|Germany|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Romania|Russian Federation 1
United States|Argentina|Brazil|Canada|Finland|France|Germany|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Czech Republic|France|Germany|Netherlands|Spain|United Kingdom 1
United States|Australia|Bulgaria|Canada|Czechia|Hungary|Poland|Russian Federation|Taiwan 1
United States|Belgium 1
United States|Belgium|Bulgaria|China|Czechia|France|Germany|Hungary|Japan|Netherlands|Poland|Spain|Turkey|United Kingdom 1
United States|Canada 1
United States|Czechia|Germany|Japan|Korea, Republic of|Netherlands|Taiwan 1
United States|Netherlands|Switzerland 1
United States|Poland 1
United States|Spain|Australia|Austria|Bulgaria|Canada|Czechia|Estonia|France|Germany|Hungary|Netherlands|Poland|Romania|Russian Federation|Slovakia|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 49
2 2
4 3
6 2
8 2
9 1
10 1
11 2
14 1
19 1
21 1
23 1
26 1
28 2
30 1
38 1
44 1
47 1
48 1
50 1
57 1
70 1
71 1
73 1
83 1
87 1
99 1
103 1
104 1
105 1
109 1
127 1
173 1
233 1

Phase

Phase Study_Count
N/A 34
Phase 3 29
Phase 4 17
Phase 1 3
Phase 2 3
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 16
2 44
3 15
4 9
5 2
7 3

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 8.0000 17.00000 42.0000 26.0000 20.0000 12
1st Qu. 60.0000 18.50000 141.0000 28.0000 159.0000 49
Median 100.0000 20.00000 240.0000 30.0000 300.0000 89
Mean 167.1515 24.66667 177.3333 198.6667 305.7931 132
3rd Qu. 200.0000 28.50000 245.0000 285.0000 458.0000 150
Max. 611.0000 37.00000 250.0000 540.0000 750.0000 482

Trial Group Type

group_type Group_Count
Experimental 99
Active Comparator 55
Placebo Comparator 36
Other 18
No Intervention 8

Intervention Model

intervention_model Study_Count
Parallel Assignment 65
Single Group Assignment 15
Crossover Assignment 5
Sequential Assignment 3
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 63
Other 9
Basic Science 4
Diagnostic 4
Prevention 3
Screening 2
Device Feasibility 1
Health Services Research 1
Supportive Care 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
France 8
NA 7
United States 6
Germany 5
Denmark 3
Sweden 2
United Kingdom 2
Belgium|France|Netherlands 1
Canada 1
Germany|Belgium|Greece|Italy|Spain|United Kingdom 1
Germany|United Kingdom 1
Italy 1
Martinique 1
Norway 1
Portugal 1
Romania 1
Russian Federation 1
Switzerland 1
Tunisia 1
Turkey 1

Sites per Study

Site_count Study_Count
1 32
2 2
6 2
9 1
10 1
14 2
15 1
18 1
25 1
38 1
100 1
180 1

Enrollment Metrics

Measure Observational
Min 20.000
1st Qu 116.250
Median 467.000
Mean 1181.478
3rd Qu 927.000
Max 21108.000

Observation Model

observational_model Study_Count
Cohort 36
Case-Control 4
Case-Only 3
NA 2
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 38
Cross-Sectional 4
Retrospective 3
NA 1

Registries

Studies by Country

Country Study_Count
NA 2
Denmark 1
United States 1

Sites per Study

Site_count Study_Count
1 3
11 1

Enrollment Metrics

Measure Registries
Min 216
1st Qu 3804
Median 12500
Mean 31304
3rd Qu 40000
Max 100000

Registry Model

observational_model Study_Count
Cohort 3
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 3
Other 1

Follow-up

target_duration Study_Count
1 Month 1
15 Years 1
2 Months 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03050203 Custom Pack in Spine Surgery https://ClinicalTrials.gov/show/NCT03050203 Completed Istituto Ortopedico Rizzoli 2016-06-16
NCT04285229 A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT04285229 Recruiting Eli Lilly and Company 2021-03-31
NCT04169373 A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT04169373 Recruiting AbbVie 2023-02-20
NCT04163016 A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) https://ClinicalTrials.gov/show/NCT04163016 Recruiting UCB Pharma 2022-08-31
NCT03733925 A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis https://ClinicalTrials.gov/show/NCT03733925 Recruiting Johnson & Johnson Private Limited 2021-01-25
NCT03358134 Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis https://ClinicalTrials.gov/show/NCT03358134 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2017-07-31
NCT03319264 Sarcopenia in Axial and Peripheral Spondyloarthropathies https://ClinicalTrials.gov/show/NCT03319264 Completed Hospices Civils de Lyon 2018-07-04
NCT03287596 Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI https://ClinicalTrials.gov/show/NCT03287596 Recruiting University Hospital, Bordeaux 2022-04-01
NCT03270501 Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation https://ClinicalTrials.gov/show/NCT03270501 Recruiting University Ghent 2020-12-31
NCT03253796 Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (MK-8259-038) https://ClinicalTrials.gov/show/NCT03253796 Active, not recruiting Merck Sharp & Dohme Corp. 2021-06-15
NCT03248518 Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03248518 Active, not recruiting University of Aberdeen 2020-10-31
NCT03190603 Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03190603 Completed Armed Forces Capital Hospital, Republic of Korea 2018-06-05
NCT03187444 Cardiovascular Risk and Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT03187444 Recruiting University Hospital, Clermont-Ferrand 2036-10-24
NCT03159767 A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03159767 Completed Western Health and Social Care Trust 2018-05-02
NCT03136861 SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis https://ClinicalTrials.gov/show/NCT03136861 Completed Novartis 2019-02-15
NCT03129100 A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03129100 Active, not recruiting Eli Lilly and Company 2020-05-26
NCT03074656 The Norwegian Drug Monitoring Study https://ClinicalTrials.gov/show/NCT03074656 Active, not recruiting Diakonhjemmet Hospital 2021-01-01
NCT03072836 Study of Gut Microbiota in Crohn’s Disease Patients Suffering From Spondylarthritis https://ClinicalTrials.gov/show/NCT03072836 Recruiting Central Hospital, Nancy, France 2020-05-15
NCT03064815 The SpACE Study - Small Bowel Crohn’s Disease and Spondyloarthropathies https://ClinicalTrials.gov/show/NCT03064815 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2016-03-31
NCT03033095 Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers https://ClinicalTrials.gov/show/NCT03033095 Completed University Hospital, Grenoble 2017-07-31
NCT03020992 A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU https://ClinicalTrials.gov/show/NCT03020992 Completed UCB Pharma 2019-12-04
NCT02985983 A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA) https://ClinicalTrials.gov/show/NCT02985983 Completed Kyowa Kirin Co., Ltd. 2019-09-23
NCT02960035 A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis https://ClinicalTrials.gov/show/NCT02960035 Completed Sun Yat-sen University 2016-09-30
NCT02896127 Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02896127 Completed Novartis 2018-05-14
NCT02869100 Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients https://ClinicalTrials.gov/show/NCT02869100 Completed Central Hospital, Nancy, France 2015-03-31
NCT02855320 Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics https://ClinicalTrials.gov/show/NCT02855320 Completed Assistance Publique - Hôpitaux de Paris 2018-11-26
NCT02818478 Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis https://ClinicalTrials.gov/show/NCT02818478 Completed Parker Research Institute 2016-12-31
NCT02771210 Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site https://ClinicalTrials.gov/show/NCT02771210 Completed Novartis 2019-12-11
NCT02757352 A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02757352 Completed Eli Lilly and Company 2019-03-01
NCT02744014 Add-on Therapy for Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02744014 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2017-03-22
NCT02696798 A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02696798 Completed Eli Lilly and Company 2018-05-18
NCT02696785 A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02696785 Completed Eli Lilly and Company 2017-12-08
NCT02696031 Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02696031 Active, not recruiting Novartis 2019-07-01
NCT02038426 Ultrasonography Assessment of Peripheral Entheses in Axial Spondyloarthritis and in Healthy Subjects, Athletes or Not https://ClinicalTrials.gov/show/NCT02038426 Completed Assistance Publique Hopitaux De Marseille 2014-08-31
NCT02573298 Cryotherapy and Doppler in Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT02573298 Completed Centre Hospitalier Universitaire de Besancon 2017-03-09
NCT03926195 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03926195 Recruiting Galapagos NV 2021-01-31
NCT02552212 Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS https://ClinicalTrials.gov/show/NCT02552212 Active, not recruiting UCB Pharma 2018-04-30
NCT02374749 COMorbidities and EDucation in SPondyloArthritis Study https://ClinicalTrials.gov/show/NCT02374749 Completed Assistance Publique - Hôpitaux de Paris 2017-10-16
NCT02364479 Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein https://ClinicalTrials.gov/show/NCT02364479 Completed Sun Yat-sen University 2016-07-28
NCT02356874 The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis https://ClinicalTrials.gov/show/NCT02356874 Completed Diakonhjemmet Hospital 2016-12-31
NCT02154425 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers https://ClinicalTrials.gov/show/NCT02154425 Completed UCB Pharma 2015-12-31
NCT02148640 The NOR-SWITCH Study https://ClinicalTrials.gov/show/NCT02148640 Completed Diakonhjemmet Hospital 2016-06-30
NCT02098694 Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis https://ClinicalTrials.gov/show/NCT02098694 Completed Norwegian University of Science and Technology 2015-04-30
NCT02089529 Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs https://ClinicalTrials.gov/show/NCT02089529 Completed University Hospital of North Norway 2015-01-31
NCT01298531 A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT01298531 Completed Pfizer 2013-01-31
NCT03359642 Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy https://ClinicalTrials.gov/show/NCT03359642 Recruiting University Hospital, Bordeaux 2021-06-30
NCT03928704 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03928704 Recruiting UCB Pharma 2021-02-02
NCT02019602 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta https://ClinicalTrials.gov/show/NCT02019602 Completed UCB Pharma 2016-10-31
NCT01808118 Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT01808118 Completed AbbVie 2017-02-21
NCT01718951 Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial https://ClinicalTrials.gov/show/NCT01718951 Completed Tuen Mun Hospital 2014-03-31
NCT01610947 Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity https://ClinicalTrials.gov/show/NCT01610947 Completed University Hospital, Montpellier 2018-10-31
NCT01590966 Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis https://ClinicalTrials.gov/show/NCT01590966 Completed University Hospital, Ghent 2019-03-26
NCT01583374 Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01583374 Completed Amgen 2014-02-24
NCT01453725 Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) https://ClinicalTrials.gov/show/NCT01453725 Completed Merck Sharp & Dohme Corp. 2014-03-11
NCT01426815 Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria https://ClinicalTrials.gov/show/NCT01426815 Completed University Hospital, Ghent 2019-03-31
NCT03622658 Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03622658 Completed Izana Bioscience Ltd. 2020-02-04
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT04436640 Enrolling by invitation UCB Pharma 2023-11-30
NCT04200690 Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases https://ClinicalTrials.gov/show/NCT04200690 Recruiting University of Aarhus 2022-07-31
NCT04156620 Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA https://ClinicalTrials.gov/show/NCT04156620 Recruiting Novartis 2021-08-09
NCT04143165 Ultrasound Guided Epidural Block in Axial SPA https://ClinicalTrials.gov/show/NCT04143165 Completed Sohag University 2020-01-12
NCT04001673 Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis. https://ClinicalTrials.gov/show/NCT04001673 Completed Hôpital Cochin 2018-09-15
NCT03974308 Effectiveness of Spa Treatment, Outpatient Physiotherapy and no Physiotherapy in Spine Osteoarthritis https://ClinicalTrials.gov/show/NCT03974308 Enrolling by invitation University of Rzeszow 2019-09-30
NCT03932019 Study of Jitongning Tablet to Treat Spondyloarthritis https://ClinicalTrials.gov/show/NCT03932019 Recruiting Tasly Pharmaceuticals, Inc. 2021-04-30
NCT03906136 AScalate: Treat-to-target in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03906136 Recruiting Novartis 2021-12-31
NCT03762824 Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease https://ClinicalTrials.gov/show/NCT03762824 Active, not recruiting Region Skane 2018-09-03
NCT03738956 Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial https://ClinicalTrials.gov/show/NCT03738956 Recruiting Globe Pharmaceuticals Limited 2018-12-30
NCT03683602 Effect of Chosen Treatment Methods in Patients With Cervical Spine Osteoarthritis https://ClinicalTrials.gov/show/NCT03683602 Completed Jagiellonian University 2013-04-30
NCT03668925 Association Between Hidradenitis Suppurativa and Spondyloarthritis https://ClinicalTrials.gov/show/NCT03668925 Completed CHU de Reims 2014-04-01
NCT03639740 Treat-to-target With Secukinumab in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03639740 Recruiting Rigshospitalet, Denmark 2021-02-28
NCT03582332 Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients https://ClinicalTrials.gov/show/NCT03582332 Completed Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 2016-06-23
NCT03552276 A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis. https://ClinicalTrials.gov/show/NCT03552276 Active, not recruiting Sun Pharma Global FZE 2023-06-30
NCT03542955 Pulse Shortwave Therapy in Cervical Osteoarthritis https://ClinicalTrials.gov/show/NCT03542955 Completed BioElectronics Corporation 2019-07-30
NCT03486613 PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis https://ClinicalTrials.gov/show/NCT03486613 Completed Aalborg University Hospital 2019-09-12
NCT03473665 Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03473665 Completed Columbia University 2019-08-02
NCT03445845 Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03445845 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-11-30
NCT03430388 Yellow Fever Vaccine in Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03430388 Completed University of Sao Paulo General Hospital 2018-03-24
NCT03425812 Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission https://ClinicalTrials.gov/show/NCT03425812 Recruiting The First Affiliated Hospital of Xiamen University 2020-01-20
NCT03420404 Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03420404 Recruiting Singapore General Hospital 2020-10-31
NCT01258738 Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes https://ClinicalTrials.gov/show/NCT01258738 Completed Pfizer 2012-11-30
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing https://ClinicalTrials.gov/show/NCT01174186 Completed Regionshospitalet Silkeborg 2013-06-30
NCT01087762 Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT01087762 Completed UCB Pharma 2011-10-31
NCT01064856 Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA) https://ClinicalTrials.gov/show/NCT01064856 Completed AbbVie 2011-08-31
NCT01040195 Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain https://ClinicalTrials.gov/show/NCT01040195 Completed Sanjay Gandhi Postgraduate Institute of Medical Sciences 2012-11-30
NCT01029847 Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis https://ClinicalTrials.gov/show/NCT01029847 Completed Rigshospitalet, Denmark 2013-12-31
NCT00939003 Study of Adalimumab in Patients With Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT00939003 Completed AbbVie 2011-02-28
NCT03092583 Analysis of DNA Methylation in Spondyloarthritis https://ClinicalTrials.gov/show/NCT03092583 Recruiting Centre Hospitalier Universitaire de Besancon 2020-03-31
NCT00844805 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) https://ClinicalTrials.gov/show/NCT00844805 Completed Merck Sharp & Dohme Corp. 2011-04-30
NCT00722514 Evaluation of a Patient Education Program for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00722514 Completed Rehazentrum Bad Eilsen 2001-02-28
NCT00591201 Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies https://ClinicalTrials.gov/show/NCT00591201 Completed Hospital General de Mexico 2007-06-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03345355 MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03345355 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-07-31
NCT03327454 Benepali® PEN Patient Satisfaction Survey https://ClinicalTrials.gov/show/NCT03327454 Completed Biogen 2018-06-21
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03131661 A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs https://ClinicalTrials.gov/show/NCT03131661 Active, not recruiting Janssen-Cilag S.p.A. 2021-06-30
NCT03043846 Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis) https://ClinicalTrials.gov/show/NCT03043846 Completed Association de Recherche Clinique en Rhumatologie 2019-06-18
NCT03039088 PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients https://ClinicalTrials.gov/show/NCT03039088 Completed Association de Recherche Clinique en Rhumatologie 2016-10-04
NCT02988674 A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation https://ClinicalTrials.gov/show/NCT02988674 Completed AbbVie 2019-10-16
NCT02948608 Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis https://ClinicalTrials.gov/show/NCT02948608 Active, not recruiting Svendborg Hospital 2019-03-31
NCT02709694 Imaging Biomarkers in Crohn’s Associated Spondyloarthritis https://ClinicalTrials.gov/show/NCT02709694 Active, not recruiting Hospital for Special Surgery, New York 2023-01-31
NCT02486302 A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. https://ClinicalTrials.gov/show/NCT02486302 Completed Pfizer 2017-12-11
NCT02402894 Follow-up of Person-centered Care of Young Adults With Rheumatic Disease https://ClinicalTrials.gov/show/NCT02402894 Active, not recruiting Vastra Gotaland Region 2020-12-31
NCT02354105 A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life https://ClinicalTrials.gov/show/NCT02354105 Completed UCB Pharma 2018-03-09
NCT01314547 Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort https://ClinicalTrials.gov/show/NCT01314547 Completed Assistance Publique - Hôpitaux de Paris 2011-12-31
NCT01302730 Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study https://ClinicalTrials.gov/show/NCT01302730 Completed Stanford University 2012-03-31
NCT01277419 German Spondyloarthritis Inception Cohort https://ClinicalTrials.gov/show/NCT01277419 Recruiting Charite University, Berlin, Germany 2030-07-31
NCT02011386 Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT02011386 Completed Rigshospitalet, Denmark 2017-02-14
NCT01969188 A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement https://ClinicalTrials.gov/show/NCT01969188 Active, not recruiting Hospital for Special Surgery, New York 2022-12-31
NCT01947465 Immunogenicity and Safety of Vaccinations in Immunocompromised Persons https://ClinicalTrials.gov/show/NCT01947465 Completed University of Zurich 2015-12-31
NCT01833468 Functional Limitations Due To The Foot Involvement In Spondyloarthritis https://ClinicalTrials.gov/show/NCT01833468 Completed Vakif Gureba Training and Research Hospital 2013-04-30
NCT01327638 Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082) https://ClinicalTrials.gov/show/NCT01327638 Completed Merck Sharp & Dohme Corp. 2018-09-24
NCT04369651 Socio-economic Determinants for Acceptance and Choice of Biological Treatment https://ClinicalTrials.gov/show/NCT04369651 Completed National Center for Rheumatic Diseases, Nepal 2019-12-31
NCT04355923 Confinement and Spondyloarthritis Treatment https://ClinicalTrials.gov/show/NCT04355923 Recruiting Centre Hospitalier Universitaire de Nice 2020-05-15
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747 Recruiting Aalborg University Hospital 2021-08-01
NCT04315090 Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion https://ClinicalTrials.gov/show/NCT04315090 Recruiting Mayo Clinic 2022-05-01
NCT04212806 French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA) https://ClinicalTrials.gov/show/NCT04212806 Recruiting University Hospital, Grenoble 2020-07-31
NCT04191395 Evolution and Treatments of Chronic Inflammatory Systemic Diseases https://ClinicalTrials.gov/show/NCT04191395 Recruiting Centre Hospitalier Universitaire de Besancon 2029-12-31
NCT04089514 A Real-world Study of Imraldi® Use https://ClinicalTrials.gov/show/NCT04089514 Recruiting Biogen 2021-06-30
NCT03999489 Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain https://ClinicalTrials.gov/show/NCT03999489 Completed Centre Hospitalier Universitaire de Nīmes 2015-06-30
NCT03993847 CLassification of Axial SpondyloarthritiS Inception Cohort https://ClinicalTrials.gov/show/NCT03993847 Recruiting Spondyloarthritis Research and Treatment Network 2023-01-31
NCT03863756 Performance of EOS Imaging System in the Assessment of Spondyloarthritis Structural Changes Compared With Standard Radiography https://ClinicalTrials.gov/show/NCT03863756 Active, not recruiting Medical School of Tunisia 2020-08-30
NCT03839862 Faecal Analyses in Spondyloarthritis Therapy https://ClinicalTrials.gov/show/NCT03839862 Recruiting Region Skane 2021-12-31
NCT03818958 Seric Calprotectine in Spondyloarthritis https://ClinicalTrials.gov/show/NCT03818958 Completed Centre Hospitalier Universitaire de Nice 2018-01-15
NCT03817983 MRE as a Screening Tool for axSpA in IBD https://ClinicalTrials.gov/show/NCT03817983 Recruiting Cambridge University Hospitals NHS Foundation Trust 2020-02-08
NCT03770884 Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs) https://ClinicalTrials.gov/show/NCT03770884 Recruiting Assistance Publique - Hôpitaux de Paris 2019-07-31
NCT03564743 Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology. https://ClinicalTrials.gov/show/NCT03564743 Recruiting University Hospital Center of Martinique 2020-11-30
NCT03533569 Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis https://ClinicalTrials.gov/show/NCT03533569 Recruiting St George’s, University of London 2021-04-02
NCT03496831 Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs https://ClinicalTrials.gov/show/NCT03496831 Completed Rigshospitalet, Denmark 2017-12-31
NCT01219257 Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy https://ClinicalTrials.gov/show/NCT01219257 Completed Diakonhjemmet Hospital 2016-01-31
NCT03100734 Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel https://ClinicalTrials.gov/show/NCT03100734 Completed Biogen 2018-11-30
NCT04139954 Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs https://ClinicalTrials.gov/show/NCT04139954 Recruiting Turkish League Against Rheumatism 2020-03-01
NCT01422694 Natural History and Development of Spondyloarthritis https://ClinicalTrials.gov/show/NCT01422694 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00794404 Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy https://ClinicalTrials.gov/show/NCT00794404 Completed Groupe Français d’Etude Génétique des Spondylarthropathies 2010-03-31
NCT00768950 The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides https://ClinicalTrials.gov/show/NCT00768950 Completed Carol Davila University of Medicine and Pharmacy 2013-08-31
NCT00741793 Biologic Treatment Registry Across Canada https://ClinicalTrials.gov/show/NCT00741793 Completed Janssen Inc. 2018-06-27
NCT00726765 Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED) https://ClinicalTrials.gov/show/NCT00726765 Completed Merck Sharp & Dohme Corp. 2010-05-31
NCT00383617 Referral Recommendations for Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT00383617 Completed Charite University, Berlin, Germany 2007-04-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03214263 Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03214263 Recruiting Rigshospitalet, Denmark 2024-12-31
NCT02530268 The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry https://ClinicalTrials.gov/show/NCT02530268 Enrolling by invitation Corrona, LLC. 2100-12-31
NCT02285868 ATI Evidence-based Guide Investigating Clinical Services https://ClinicalTrials.gov/show/NCT02285868 Recruiting ATI Holdings, LLC 2024-01-31
NCT04095169 Biomarkers in Early-stage Spondyloarthritis https://ClinicalTrials.gov/show/NCT04095169 Active, not recruiting Spine Centre of Southern Denmark 2019-12-31